The largest database of trusted experimental protocols

Anti c myc antibody clone 9e10

Manufactured by Santa Cruz Biotechnology
Sourced in United States

The Anti-c-myc antibody (clone 9E10) is a widely used monoclonal antibody that specifically binds to the c-myc protein, a transcription factor involved in regulating cell growth and proliferation. This antibody can be used for various applications such as Western blotting, immunoprecipitation, and immunocytochemistry.

Automatically generated - may contain errors

4 protocols using anti c myc antibody clone 9e10

1

Binding Assay for Recombinant Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The binding assay was performed using Meso Scale Discovery 384 well high bind plates56 (link). All binding experiments were carried out at 22 °C. Liposomes (2 μL) were passively adsorbed on the electrode surface for 1 h, and residual sites on the surface were blocked for 1 h with 0.25% porcine gelatin (Sigma-Aldrich) in TRIS buffer (50 mM Tris, 150 mM NaCl, pH 8.0). After three washing steps with TRIS buffer, serial dilutions of recombinant protein in blocking buffer was added to the respective wells and incubated for 2 h. Unbound protein was removed, and anti-c-myc antibody (clone 9E10, Santa Cruz Biotechnology) at 1.25 µg/mL concentration in 0.25% porcine gelatin was applied for 1 h followed by three subsequent wash steps with TRIS buffer. For detection, a secondary anti-mouse antibodies labeled with Sulfo-TAG (Meso Scale Discovery) was used at 1.25 μg/mL in blocking buffer for 1 h in the dark. Free secondary antibody was washed off, and reading buffer (surfactant-free reading buffer from Meso Scale Discovery) was added. The readout was performed on a Meso Scale Discovery SECTOR Imager 6000 chemiluminescence reader. Data were analyzed with GraphPad Prism 6.07. First, signal from PC/cholesterol (70/30 mol %) vesicles was subtracted as a background. Next, a non-linear curve fitting was applied, and the binding kinetics were calculated using one site—specific binding fitting.
+ Open protocol
+ Expand
2

Immunoblotting and BrdU Immunofluorescence Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immuoblots and BrdU immunofluorescence assays were carried out as described previously [13 (link),14 (link)]. The following antibodies (all from Santa Cruz Biotechnology) were used: anti-p21 antibody (clones M-19, C-19 and F-5), anti-TRIM3 antibody (clone 27), anti-c-Myc antibody (clone 9E10), anti-HA (haemagglutinin) antibody (clone Y-11), anti-tubulin antibody, anti-GST antibody (clone B-14), anti-BSA antibody (clone A23-A/D3) and anti-p27 antibody (clone C-19).
+ Open protocol
+ Expand
3

Quantification of c-Myc Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human insulin (Humulin R) was obtained from Eli Lilly (Indianapolis, IN, U.S.A.). The analog of adenosine monophosphate 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) was obtained from TOCRIS (catalogue #2840) and ionomycin was obtained from Sigma-Aldrich (catalogue #I9657). The primary monoclonal mouse anti-c-Myc antibody (clone 9E10) was purchased from Santa Cruz Biotechnology (Dallas, TX, U.S.A.), and the polyclonal rabbit anti-c-Myc antibody was purchased from Millipore-Sigma (St. Louis, MO, U.S.A.). Secondary antibodies, including goat anti-rabbit IgG H&L (Alexa Fluor® 647) and goat anti-rabbit IgG H&L (Cy3®), were purchased from ABCAM, while goat anti-rabbit H&L HRP was from Thermo Scientific (Invitrogen®). Sigma FAST OPD (o-phenylenediamine dihydrochloride peroxidase substrate) tablets were purchased from SIGMA-ALDRICH (Catalogue #P9187).
+ Open protocol
+ Expand
4

Production and Purification of scFv Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
scFv antibody fragments were prepared according to Sokolowska-Wedzina et al. [54 (link)]. Briefly, purified pIT2 plasmids with scFv sequences were electroporated into E. coli HB2151 cells (Source BioScience). The bacteria were grown in 2× TY media supplemented with 100 μg/mL ampicillin and 0.1% glucose to OD600 = 0.8 and the production of protein was induced with 0.5 mM IPTG. Cells were cultured at 30 °C, 180 rpm, overnight and then the cultures were harvested, centrifuged twice at 4000 rcf, 4 °C for 40 min, and filtered using a Stericap PLUS bottle filter device (Merck Millipore, Darmstadt, Germany). scFv antibody fragments were purified from the supernatants by affinity chromatography using rProtein A Sepharose Fast Flow Resin (GE Healthcare), following the same protocol as described previously by our group for ECD_FGFR-Fc proteins [52 (link)]. Purified scFvs were analyzed by SDS-PAGE, Western blotting using anti-c-myc antibody, clone 9E10 (Santa Cruz Biotechnology Inc., Dallas, TX, USA), and mass spectrometry. The molecular masses of the proteins were verified by MALDI-TOF/TOF 4800 (Applied Biosystems, Foster City, CA, USA), using α-cyano-4-hydroxycinnamic acid as a matrix.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!